Aggressive childhood cancer could be treated by combining DNA-damage-targeting drugs
An aggressive form of the childhood cancer neuroblastoma could be treatable with two cancer drugs currently used in the treatment of colon and ovarian cancer, a study led by researchers at The Institute of Cancer Research, London, suggests. A team led by researchers at the ICR modified neuroblastoma cells in the lab to silence a gene called ATRX, mutations to […]
Continue reading »